Initial Public Offering (IPO): Registration Statement (General Form) — Form S-1 Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: S-1 Registration Statement (General Form) HTML 845K
2: EX-3.1 Articles of Incorporation/Organization or By-Laws HTML 9K
3: EX-3.2 Articles of Incorporation/Organization or By-Laws HTML 7K
4: EX-3.3 Articles of Incorporation/Organization or By-Laws HTML 39K
5: EX-3.4 Articles of Incorporation/Organization or By-Laws HTML 7K
6: EX-3.5 Articles of Incorporation/Organization or By-Laws HTML 57K
7: EX-10.1 Material Contract HTML 61K
8: EX-10.2 Material Contract HTML 56K
9: EX-10.3 Material Contract HTML 51K
10: EX-10.4 Material Contract HTML 43K
11: EX-10.5 Material Contract HTML 59K
12: EX-10.6 Material Contract HTML 55K
13: EX-10.7 Material Contract HTML 166K
14: EX-10.8 Material Contract HTML 138K
15: EX-10.9 Material Contract HTML 26K
16: EX-23.1 Consent of Experts or Counsel HTML 8K
17: EX-99.1 Miscellaneous Exhibit HTML 9K
In accordance with Rule 438 under the Securities
Act of 1933, as amended (the “Securities Act”), the undersigned hereby consents to being named as a director nominee
and impending board member of Akers Biosciences, Inc. (the “Company”) in the Company’s Registration Statement
on Form S-1 (Registration No. 333-187094) and in all amendments (including post-effective amendments) thereto.